Developer docs
API playgroundTry for free, no card

Search company profiles

International Diabetes Federation (IDF)

Full company profile

uuid000gqzs

Namestring
International Diabetes Federation (IDF)
Legal namestring
AISBL International Diabetes Federation
Websiteurl
idf.org
Company typeenum
Private
Founded yearint
1950
Descriptiontext

The International Diabetes Federation (IDF), founded in 1950 and registered in Brussels, Belgium as an AISBL (International Non-Profit Association), is the world's largest umbrella organization for diabetes, federating 251 national diabetes associations across 158 countries and territories. IDF's functional mission is to improve the lives of people living with diabetes and prevent the disease in those at risk, delivered through four interlocking activity lines: global advocacy (including UN and WHO engagement and the World Diabetes Day campaign reaching over 1 billion people in 160+ countries annually), education (the multilingual IDF School of Diabetes, clinical practice recommendations, and the biennial World Diabetes Congress with 6,800–12,000 delegates), epidemiology (the IDF Diabetes Atlas, the authoritative global dataset on diabetes prevalence, mortality, and costs), and humanitarian relief.

The organization's core technology stack is a portfolio of digital platforms rather than a unified product: the IDF Diabetes Atlas (diabetesatlas.org) for epidemiological data, the IDF School of Diabetes (idfdiabeteschool.org) for online courses in multiple languages, the World Diabetes Day app and microsite, the Diabetes Voice online news platform, the KiDS school program, the Blue Circle Voices and Young Leaders in Diabetes advocacy networks, and a suite of additional microsites. AI is limited to a policy/governance posture (2026 Responsible AI position paper), not operational deployment. IDF holds the registered Blue Circle trademark as the global symbol for diabetes.

IDF is funded through a hybrid non-profit model: individual membership subscriptions (100 EUR/year), association membership dues, biennial congress registration fees, corporate partnerships and sponsorships (notably Sun Life for type 2 risk reduction and Sanofi for training programs), grants, and individual donations. It employs 51–100 staff at its Brussels headquarters and coordinates seven regional offices (Africa, Europe, Middle East and North Africa, North America and Caribbean, South and Central America, South-East Asia, Western Pacific). Customer segments include national diabetes associations, healthcare professionals, people living with diabetes, governments/policymakers, and researchers — distributed across 158 countries with no single anchor dependency.

Short descriptiontext

The International Diabetes Federation (IDF) is a Brussels-headquartered non-profit umbrella organization, founded in 1950, that federates 251 national diabetes associations across 158 countries. It delivers global diabetes advocacy, education, epidemiological data (IDF Diabetes Atlas), and the biennial World Diabetes Congress serving healthcare professionals, people living with diabetes, and policymakers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBrussels, Belgium
HQ citystring
Brussels
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diabetes advocacy, global health federation, medical education, clinical guidelines, epidemiology research
Industry1 code
1Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Social Advocacy Organizations8133
SIC code1 code
  • Services-Membership Organizations8600
Product category
Non-Profit Health Federation / Diabetes Advocacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Membership Fees
TypeSubscription Recurring
Description

Individual membership fees at 100 EUR per year; association membership provides voting rights in General Assemblies and regional councils.

idf.org
2Congress and Events
TypeProfessional Services
Description

Revenue generated from IDF World Diabetes Congress registration fees, which attracts thousands of international delegates.

idf.org
3Partnerships and Corporate Sponsorships
TypeLicensing Royalties
Description

Collaborations with companies like Sun Life and Sanofi for type 2 diabetes risk reduction and training programs.

idf.org
4Donations
TypeAffiliate Referral
Description

Voluntary contributions from individuals and organizations supporting IDF's mission to improve diabetes care in low and middle-income countries.

idf.org
5Fellowship Program
TypeSubscription Recurring
Description

Professional fellowship program with associated subscription fees.

idf.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Individual Membership - 100 EUR/year
ModelSubscriptionBilling cadenceAnnual
Notes

Individual membership provides access to a global network committed to improving the lives of people living with diabetes and preventing diabetes in those at risk. Also provides a platform for collaboration, learning, and policy influence at national, regional, and international levels.

idf.org
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1World Diabetes Day
Description

Global diabetes awareness campaign marked every year on 14 November, reaching over 1 billion people in more than 160 countries

idf.org
+6 more records
Core offering1 text field

IDF is a non-profit umbrella organization representing 251 national diabetes associations across 158 countries, delivering global diabetes advocacy, education, epidemiological research, and humanitarian relief. Its offerings include the IDF Diabetes Atlas data platform, the IDF School of Diabetes online courses, the biennial World Diabetes Congress, awareness campaigns like World Diabetes Day, advocacy networks, clinical practice guidelines, and a network of Centres of Excellence.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • World Diabetes Day reaches over 1 billion people in more than 160 countries
+3 more records
Product overview1 text field

The International Diabetes Federation (IDF) operates as an umbrella organization representing 251 national diabetes associations across 158 countries. Rather than a single product, IDF offers a portfolio of interconnected platforms, programs, and resources. Core offerings include the IDF Diabetes Atlas for global epidemiological data, the IDF School of Diabetes for professional and patient education, and the World Diabetes Congress as the premier scientific gathering. Supporting these are awareness initiatives like World Diabetes Day, advocacy networks (Blue Circle Voices, Young Leaders in Diabetes), digital platforms (Diabetes Voice, Understanding Diabetes), and the KiDS school program. IDF also provides clinical guidelines, risk assessment tools, fellowship programs, and a Centres of Excellence network. The organization functions as a membership-based federation rather than a technology company, with its digital presence primarily serving educational, awareness, and advocacy purposes rather than commercial product delivery.

Product and service14 records
1IDF Diabetes Atlas
CategoryResearch/Epidemiology Platform
2IDF School of Diabetes
CategoryEducation Platform
3World Diabetes Day
CategoryAwareness Campaign
4World Diabetes Congress
CategoryScientific Congress
5Diabetes Voice
CategoryOnline News Platform
6Kids and Diabetes in Schools (KiDS)
CategoryEducation Program
7Blue Circle Voices
CategoryAdvocacy Network
8Young Leaders in Diabetes
CategoryAdvocacy Network
9IDF Fellowship Programme
CategoryProfessional Development
10IDF Centres of Excellence
CategoryHealthcare Network
11IDF Advocacy Academy
CategoryAdvocacy Training
12IDF Global Clinical Practice Recommendations
CategoryClinical Guidelines
13Understanding Diabetes
CategoryEducation Resource
14Type 2 Diabetes Risk Assessment
CategoryOnline Screening Tool
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-06-15
Description

IDF and Sun Life partner to support type 2 diabetes risk reduction. This partnership aims to improve diabetes prevention efforts and support IDF's mission to improve lives of people living with diabetes.

Strategic tierResearchTypeStrategic or Co-development Partner
Description

Research partnership for Type 5 diabetes recognition. Meredith Hawkins at Albert Einstein College of Medicine conducted the 2022 trial in south India that demonstrated the unique metabolic profile of Type 5 diabetes.

Strategic tierPolicyTypeStrategic or Co-development Partner
Description

WHO previously acknowledged Type 5 diabetes (J-type diabetes) in the 1980s before dropping it in 1999. IDF officially recognized Type 5 diabetes in 2024, working to improve diagnosis and treatment for patients globally.

Strategic tierJoint InitiativeTypeStrategic or Co-development Partner
Description

Joint policy brief with ISPAD providing recommendations to advance type 1 diabetes screening and early diagnosis. The 'Detect early, act early' policy brief is for advocates, healthcare professionals and policymakers.

Strategic tierCentre Of ExcellenceTypeStrategic or Co-development Partner
Description

CMC Vellore awarded Centre of Excellence status by IDF for its Department of Endocrinology, Diabetes and Metabolism based on assessment of education, training, patient care, outreach, and research capacity. CMC also holds ICMR Collaborating Centre of Excellence for Diabetes distinction.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

IDF-Sanofi Strategic Diabetes Training Collaborations focusing on diabetes education and training programs. Also sponsor of the 'Doing Well with Diabetes' podcast series and KiDS program.

7251 National Diabetes Associations
Strategic tierCoreTypeGTM or Marketing Partner
Description

IDF's core membership network comprising 251 national diabetes associations in 158 countries and territories. These associations serve as local implementing partners for IDF's global programs and advocacy initiatives.

idf.org
Strategic tierPolicyTypeStrategic or Co-development Partner
Description

IDF engages with UN agencies to shape the global health agenda and effect change for people living with diabetes through coordinated advocacy efforts.

9Optima (Website Hosting)
Strategic tierMinorTypeOthers
Description

Website hosting services provider for IDF's online platforms including idf.org and other IDF websites.

idf.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Union for International Cancer Control (UICC)
TypeDirect peer
Description

Geneva-based umbrella organization of 1,100+ cancer organizations in 170+ countries. Operates World Cancer Day and a global congress structure analogous to IDF's World Diabetes Day and World Diabetes Congress, making it a direct structural peer in the global NCD federation category.

TypeBroad incumbent
Description

The United Kingdom's leading diabetes charity, with significant government and NHS engagement. A regional peer comparable to a single national IDF member association but operating at a scale comparable to IDF's regional offices on its own.

TypeEmerging player
Description

U.S.-led Type 1 diabetes research and advocacy organization with substantial research funding and a globally recognized brand. Comparable to IDF in advocacy scope but narrower (Type 1 only) and with deeper research-grant funding capability—a thematic peer in the same disease space.

TypeDirect peer
Description

European scientific society for diabetes research and care, running the annual EASD Annual Meeting and the Diabetologia journal. A direct competitor in convening the global HCP audience and shaping clinical research priorities, complementing IDF's broader public-health and advocacy remit.

TypeBroad incumbent
Description

Geneva-based public-private partnership funding immunization in lower-income countries. Comparable as a global health PPP model with corporate sponsors, member-state engagement, and direct program delivery—though focused on vaccines rather than diabetes.

TypeDirect peer
Description

Geneva-based umbrella federation of 200+ cardiac foundations and societies across 100+ countries. Closest structural analog to IDF as a global, membership-based NCD federation running a World Heart Day campaign, an annual congress, and clinical guidelines—directly comparable in mission, funding model, and advocacy positioning.

TypeBroad incumbent
Description

The largest single-country diabetes organization with a much bigger budget, running the flagship Scientific Sessions conference, Diabetes Care journal, and Standards of Care guidelines. A broader incumbent peer covering the same disease but U.S.-centric, with overlapping clinical guidelines, education, and advocacy functions.

TypeDirect peer
Description

Global federation of kidney-care professionals with regional boards, a World Kidney Day campaign, and a biennial World Congress of Nephrology. Highly comparable to IDF as a global, specialty-disease federation with NCD focus and similar membership-based governance.

TypeBroad incumbent
Description

The UN specialized agency for health and a key IDF partner. While not a peer in organizational structure, WHO sets the global diabetes agenda IDF seeks to influence, including the WHO Global Diabetes Compact, making it a comparable agenda-setter in the same policy domain.

TypeDirect peer
Description

Geneva-based NCD federation representing stroke societies globally with a World Stroke Day campaign and an international congress. A direct structural and operational peer to IDF in the global NCD federation space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Diabetes Federation (IDF)

Non-Profit Health Federation / Diabetes Advocacyidf.org

The International Diabetes Federation (IDF) is a Brussels-headquartered non-profit umbrella organization, founded in 1950, that federates 251 national diabetes associations across 158 countries. It delivers global diabetes advocacy, education, epidemiological data (IDF Diabetes Atlas), and the biennial World Diabetes Congress serving healthcare professionals, people living with diabetes, and policymakers worldwide.

What International Diabetes Federation (IDF) does

The International Diabetes Federation (IDF), founded in 1950 and registered in Brussels, Belgium as an AISBL (International Non-Profit Association), is the world's largest umbrella organization for diabetes, federating 251 national diabetes associations across 158 countries and territories. IDF's functional mission is to improve the lives of people living with diabetes and prevent the disease in those at risk, delivered through four interlocking activity lines: global advocacy (including UN and WHO engagement and the World Diabetes Day campaign reaching over 1 billion people in 160+ countries annually), education (the multilingual IDF School of Diabetes, clinical practice recommendations, and the biennial World Diabetes Congress with 6,800–12,000 delegates), epidemiology (the IDF Diabetes Atlas, the authoritative global dataset on diabetes prevalence, mortality, and costs), and humanitarian relief.

The organization's core technology stack is a portfolio of digital platforms rather than a unified product: the IDF Diabetes Atlas (diabetesatlas.org) for epidemiological data, the IDF School of Diabetes (idfdiabeteschool.org) for online courses in multiple languages, the World Diabetes Day app and microsite, the Diabetes Voice online news platform, the KiDS school program, the Blue Circle Voices and Young Leaders in Diabetes advocacy networks, and a suite of additional microsites. AI is limited to a policy/governance posture (2026 Responsible AI position paper), not operational deployment. IDF holds the registered Blue Circle trademark as the global symbol for diabetes.

IDF is funded through a hybrid non-profit model: individual membership subscriptions (100 EUR/year), association membership dues, biennial congress registration fees, corporate partnerships and sponsorships (notably Sun Life for type 2 risk reduction and Sanofi for training programs), grants, and individual donations. It employs 51–100 staff at its Brussels headquarters and coordinates seven regional offices (Africa, Europe, Middle East and North Africa, North America and Caribbean, South and Central America, South-East Asia, Western Pacific). Customer segments include national diabetes associations, healthcare professionals, people living with diabetes, governments/policymakers, and researchers — distributed across 158 countries with no single anchor dependency.

International Diabetes Federation (IDF) firmographics

Firmographics
Name
International Diabetes Federation (IDF)
Legal name
AISBL International Diabetes Federation
Website
https://idf.org
Company type
Private
Founded year
1950
Operating status
Operating
Headcount range
51–100 employees
Short description
The International Diabetes Federation (IDF) is a Brussels-headquartered non-profit umbrella organization, founded in 1950, that federates 251 national diabetes associations across 158 countries. It delivers global diabetes advocacy, education, epidemiological data (IDF Diabetes Atlas), and the biennial World Diabetes Congress serving healthcare professionals, people living with diabetes, and policymakers worldwide.
Ownership category
akta.pro rank

Where International Diabetes Federation (IDF) is headquartered

Location

Headquarters

HQ city
Brussels
HQ country
Belgium
HQ region
Europe

Offices2 records

Markets served

International Diabetes Federation (IDF) business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Membership Fees: Individual membership fees at 100 EUR per year; association membership provides voting rights in General Assemblies and regional councils.
  2. Congress and Events: Revenue generated from IDF World Diabetes Congress registration fees, which attracts thousands of international delegates.
  3. Partnerships and Corporate Sponsorships: Collaborations with companies like Sun Life and Sanofi for type 2 diabetes risk reduction and training programs.
  4. Donations: Voluntary contributions from individuals and organizations supporting IDF's mission to improve diabetes care in low and middle-income countries.
  5. Fellowship Program: Professional fellowship program with associated subscription fees.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualIndividual Membership - 100 EUR/year

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

International Diabetes Federation (IDF) product offering

Product offering

Core offering

IDF is a non-profit umbrella organization representing 251 national diabetes associations across 158 countries, delivering global diabetes advocacy, education, epidemiological research, and humanitarian relief. Its offerings include the IDF Diabetes Atlas data platform, the IDF School of Diabetes online courses, the biennial World Diabetes Congress, awareness campaigns like World Diabetes Day, advocacy networks, clinical practice guidelines, and a network of Centres of Excellence.

Product overview

The International Diabetes Federation (IDF) operates as an umbrella organization representing 251 national diabetes associations across 158 countries. Rather than a single product, IDF offers a portfolio of interconnected platforms, programs, and resources. Core offerings include the IDF Diabetes Atlas for global epidemiological data, the IDF School of Diabetes for professional and patient education, and the World Diabetes Congress as the premier scientific gathering. Supporting these are awareness initiatives like World Diabetes Day, advocacy networks (Blue Circle Voices, Young Leaders in Diabetes), digital platforms (Diabetes Voice, Understanding Diabetes), and the KiDS school program. IDF also provides clinical guidelines, risk assessment tools, fellowship programs, and a Centres of Excellence network. The organization functions as a membership-based federation rather than a technology company, with its digital presence primarily serving educational, awareness, and advocacy purposes rather than commercial product delivery.

Differentiator

Problem solved

Functional benefit

Brands

  • World Diabetes Day: Global diabetes awareness campaign marked every year on 14 November, reaching over 1 billion people in more than 160 countries
  • IDF Diabetes Atlas
  • IDF School of Diabetes
  • Diabetes Voice
  • Blue Circle Voices
  • Young Leaders in Diabetes
  • Kids and Diabetes in Schools (KiDS)

Products and services

  • IDF Diabetes Atlas
  • IDF School of Diabetes
  • World Diabetes Day
  • World Diabetes Congress
  • Diabetes Voice
  • Kids and Diabetes in Schools (KiDS)
  • Blue Circle Voices
  • Young Leaders in Diabetes
  • IDF Fellowship Programme
  • IDF Centres of Excellence
  • IDF Advocacy Academy
  • IDF Global Clinical Practice Recommendations
  • Understanding Diabetes
  • Type 2 Diabetes Risk Assessment

Quantifiable outcome

  • World Diabetes Day reaches over 1 billion people in more than 160 countries
  • +3 more outcomes

Companies that use International Diabetes Federation (IDF)

Customer profile

Named customers3 records

Segments6 records

Ideal customer profiles5 records

International Diabetes Federation (IDF) technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

International Diabetes Federation (IDF) partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered major, research, policy, joint initiative, centre of excellence, core and minor.

  • Sun LifemajorStrategic or Co-development Partner · 15 June 2026IDF and Sun Life partner to support type 2 diabetes risk reduction. This partnership aims to improve diabetes prevention efforts and support IDF's mission to improve lives of people living with diabetes.
  • Albert Einstein College of MedicineresearchStrategic or Co-development PartnerResearch partnership for Type 5 diabetes recognition. Meredith Hawkins at Albert Einstein College of Medicine conducted the 2022 trial in south India that demonstrated the unique metabolic profile of Type 5 diabetes.
  • WHO (World Health Organization)policyStrategic or Co-development PartnerWHO previously acknowledged Type 5 diabetes (J-type diabetes) in the 1980s before dropping it in 1999. IDF officially recognized Type 5 diabetes in 2024, working to improve diagnosis and treatment for patients globally.
  • International Society for Pediatric and Adolescent Diabetes (ISPAD)joint initiativeStrategic or Co-development PartnerJoint policy brief with ISPAD providing recommendations to advance type 1 diabetes screening and early diagnosis. The 'Detect early, act early' policy brief is for advocates, healthcare professionals and policymakers.
  • Christian Medical College (CMC) Vellorecentre of excellenceStrategic or Co-development PartnerCMC Vellore awarded Centre of Excellence status by IDF for its Department of Endocrinology, Diabetes and Metabolism based on assessment of education, training, patient care, outreach, and research capacity. CMC also holds ICMR Collaborating Centre of Excellence for Diabetes distinction.
  • SanofimajorStrategic or Co-development PartnerIDF-Sanofi Strategic Diabetes Training Collaborations focusing on diabetes education and training programs. Also sponsor of the 'Doing Well with Diabetes' podcast series and KiDS program.
  • 251 National Diabetes AssociationscoreGTM or Marketing PartnerIDF's core membership network comprising 251 national diabetes associations in 158 countries and territories. These associations serve as local implementing partners for IDF's global programs and advocacy initiatives.
  • United Nations AgenciespolicyStrategic or Co-development PartnerIDF engages with UN agencies to shape the global health agenda and effect change for people living with diabetes through coordinated advocacy efforts.
  • Optima (Website Hosting)minorOthersWebsite hosting services provider for IDF's online platforms including idf.org and other IDF websites.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

International Diabetes Federation (IDF) competitors and assessment

Company assessment

Direct peers

  • Union for International Cancer Control (UICC): Geneva-based umbrella organization of 1,100+ cancer organizations in 170+ countries. Operates World Cancer Day and a global congress structure analogous to IDF's World Diabetes Day and World Diabetes Congress, making it a direct structural peer in the global NCD federation category.
  • European Association for the Study of Diabetes (EASD): European scientific society for diabetes research and care, running the annual EASD Annual Meeting and the Diabetologia journal. A direct competitor in convening the global HCP audience and shaping clinical research priorities, complementing IDF's broader public-health and advocacy remit.
  • World Heart Federation: Geneva-based umbrella federation of 200+ cardiac foundations and societies across 100+ countries. Closest structural analog to IDF as a global, membership-based NCD federation running a World Heart Day campaign, an annual congress, and clinical guidelines—directly comparable in mission, funding model, and advocacy positioning.
  • International Society of Nephrology (ISN): Global federation of kidney-care professionals with regional boards, a World Kidney Day campaign, and a biennial World Congress of Nephrology. Highly comparable to IDF as a global, specialty-disease federation with NCD focus and similar membership-based governance.
  • World Stroke Organization: Geneva-based NCD federation representing stroke societies globally with a World Stroke Day campaign and an international congress. A direct structural and operational peer to IDF in the global NCD federation space.

Broad incumbents

  • Diabetes UK: The United Kingdom's leading diabetes charity, with significant government and NHS engagement. A regional peer comparable to a single national IDF member association but operating at a scale comparable to IDF's regional offices on its own.
  • Gavi, the Vaccine Alliance: Geneva-based public-private partnership funding immunization in lower-income countries. Comparable as a global health PPP model with corporate sponsors, member-state engagement, and direct program delivery—though focused on vaccines rather than diabetes.
  • American Diabetes Association (ADA): The largest single-country diabetes organization with a much bigger budget, running the flagship Scientific Sessions conference, Diabetes Care journal, and Standards of Care guidelines. A broader incumbent peer covering the same disease but U.S.-centric, with overlapping clinical guidelines, education, and advocacy functions.
  • World Health Organization (WHO): The UN specialized agency for health and a key IDF partner. While not a peer in organizational structure, WHO sets the global diabetes agenda IDF seeks to influence, including the WHO Global Diabetes Compact, making it a comparable agenda-setter in the same policy domain.

Emerging players

  • JDRF (formerly Juvenile Diabetes Research Foundation): U.S.-led Type 1 diabetes research and advocacy organization with substantial research funding and a globally recognized brand. Comparable to IDF in advocacy scope but narrower (Type 1 only) and with deeper research-grant funding capability—a thematic peer in the same disease space.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

International Diabetes Federation (IDF) social profiles

Digital presence

International Diabetes Federation (IDF) compliance and trust

Trust signal

Compliance1 record

International Diabetes Federation (IDF) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Diabetes Federation (IDF) leadership team

Management profile

Number of profiles

International Diabetes Federation (IDF) funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Diabetes Federation (IDF) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Diabetes Federation (IDF)

What does International Diabetes Federation (IDF) do?

IDF is a non-profit umbrella organization representing 251 national diabetes associations across 158 countries, delivering global diabetes advocacy, education, epidemiological research, and humanitarian relief. Its offerings include the IDF Diabetes Atlas data platform, the IDF School of Diabetes online courses, the biennial World Diabetes Congress, awareness campaigns like World Diabetes Day, advocacy networks, clinical practice guidelines, and a network of Centres of Excellence.

Is International Diabetes Federation (IDF) a public or private company?

International Diabetes Federation (IDF) is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was International Diabetes Federation (IDF) founded?

International Diabetes Federation (IDF) was founded in 1950. It employs 51 to 100 people.

Where is International Diabetes Federation (IDF) based?

International Diabetes Federation (IDF) is headquartered in Brussels, Belgium, in the Europe region.

How does International Diabetes Federation (IDF) make money?

Five revenue lines are on record. Membership Fees are the primary driver. The others are congress and Events, partnerships and Corporate Sponsorships, donations and fellowship Program.

Who are International Diabetes Federation (IDF)'s main competitors?

Direct peers on record are Union for International Cancer Control (UICC), European Association for the Study of Diabetes (EASD), World Heart Federation, International Society of Nephrology (ISN) and World Stroke Organization. Broad incumbents are Diabetes UK, Gavi, the Vaccine Alliance, American Diabetes Association (ADA) and World Health Organization (WHO). JDRF (formerly Juvenile Diabetes Research Foundation) is listed as an emerging player.

Does International Diabetes Federation (IDF) have an API?

No public API is recorded for International Diabetes Federation (IDF).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooA Distinct New Type of Diabetes Has Officially Been RecognizedThe International Diabetes Federation officially recognized type 5 diabetes in 2025, a form linked to nutrient deficiency. It is thought to affect up to 25 million people, especially in low- and middle-income nations. The IDF is developing diagnostic criteria and treatment guidelines.Inc.A ‘Fad Diet’ That Works Like Medicine? Scientists Say It’s Time to Rethink FastingResearchers published an article in The Lancet Diabetes & Endocrinology calling for the American Diabetes Association (ADA) and International Diabetes Federation (IDF) to formally add intermittent fasting to their clinical guidelines for treating type 2 diabetes. The team, led by Professor Krista Varady at the University of Illinois Chicago, reviewed evidence from over 225 clinical trials and found that intermittent fasting reduced HbA1c by 0.3-1.2% in adults with type 2 diabetes, performing comparably to traditional calorie restriction. The ADA acknowledged intermittent fasting briefly in its 2023 Standards of Care but has not formally reviewed its effects on blood sugar control as of 2026.The Times of IndiaDiabetes is more than blood sugar, says global experts at diabetes convention | Thiruvananthapuram News - The Times of IndiaThe 14th Annual Global Diabetes Convention began on Friday in Kovalam, Thiruvananthapuram, India, organized by Jothydev's Professional Education Forum under the theme 'Helping You Choose the Best in Care'. International experts, including Dr. Hossam Arafa Ghazi of the International Diabetes Federation, argued that diabetes should be reframed as a bioenergetic disorder involving mitochondrial dysfunction and impaired cellular ATP production, rather than solely a blood sugar management issue. The three-day convention has brought together diabetes specialists, physicians, and researchers from India and abroad to discuss evolving approaches to diabetes care.The HinduCMC bags Centre of Excellence award for diabetesChristian Medical College (CMC) in Vellore has been awarded Centre of Excellence status by the International Diabetes Federation for its Department of Endocrinology, Diabetes and Metabolism. The recognition was based on assessment of education, training, patient care, outreach, and research capacity, acknowledging 25 years of contributions by the department. CMC also holds the distinction of being an Indian Council of Medical Research Collaborating Centre of Excellence for Diabetes.Times Kuwait25 million potentially affected by new Type 5 diabetes, IDF urges global actionThe International Diabetes Federation officially recognized a fifth form of diabetes in 2025, urging the WHO to follow suit. It affects about 25 million people worldwide, primarily in low- and middle-income countries, and is linked to chronic malnutrition. The IDF has formed a task force to develop diagnostic guidelines and treatment standards.The Times of IndiaFrom Jamaica’s J-type diabetes to WHO's reversal: A long-ignored form of diabetes gets official recognitionThe International Diabetes Federation officially recognized Type 5 diabetes in 2024, a malnutrition-linked form of the disease estimated to affect up to 25 million people globally, primarily in Asia and Africa. First identified in Jamaica in 1955 as J-type diabetes and briefly acknowledged by WHO in the 1980s before being dropped in 1999, the condition gained credibility through research by investigators like Meredith Hawkins at Albert Einstein College of Medicine, whose 2022 trial in south India demonstrated its unique metabolic profile. The recognition is expected to improve diagnosis and treatment for patients in low-resource regions like India and sub-Saharan Africa who have been misdiagnosed as Type 1 or Type 2 diabetes.The Times of IndiaThe global diabetes pandemic: Why cases could reach 900 million by 2050 and what we must do nowDiabetes cases are projected to rise from 589 million adults today to nearly 900 million by 2050, with the majority of increases concentrated in low- and middle-income countries. This surge is driven by lifestyle factors such as sedentary behavior and poor diet, placing immense strain on global healthcare systems and economies. International organizations like the International Diabetes Federation and the NIH are advocating for preventive measures including sugar taxes, affordable insulin, and lifestyle changes to mitigate the crisis.The HinduWeight loss drugs have great action, but can’t replace diet and exercise: Diabetes Federation presidentThe International Diabetes Federation president Peter Schwarz spoke in Chennai at the launch of the Federation's Global Physical Activity Consensus Group, emphasizing that while GLP-1 weight loss drugs show promising results, they cannot replace diet and exercise for metabolic regulation. Schwarz highlighted cost as a significant barrier to widespread adoption of these therapies. The article notes that approximately 70 different weight loss drug molecules are expected to launch over the next 5–10 years.The Times of Indiadiabetes: Type 5 diabetes: The shocking new threat hitting children and teens – what you must know - The Economic TimesThe International Diabetes Federation officially recognized Type 5 Diabetes in April 2025 as a distinct form of diabetes stemming from impaired pancreatic development caused by prolonged childhood malnutrition. The condition, which primarily affects lean, insulin-deficient but not insulin-resistant patients, predominantly impacts adolescents and young adults in low- and middle-income countries in Asia and Africa, with an estimated 20 to 25 million people living with this condition globally. The IDF's formal classification aims to establish proper diagnostic guidelines and enable cost-effective oral treatments rather than insulin injections in resource-limited settings.Diabetes VoiceRiding the AI wave to transform diabetes careThe International Diabetes Federation has established a new Technology and AI Working Group to explore how emerging technologies can support diabetes prevention and care in diverse settings. This initiative follows growing evidence from various countries, including India, Egypt, and Italy, that AI-driven tools such as SMS coaching and mobile screening apps are effectively improving access to diabetes management in resource-limited areas.